Cancer.Net   
 Journal of Clinical Oncology   
 Journal of Oncology Practice   
 ASCO News & Forum   
 The ASCO Cancer Foundation   
 ASCO Press Center   
2009 GI Symposium  


HIGHLIGHTS
Resources for doctors and patients affected by the Gulf Coast hurricanes
ASCO Joins Frosted Pink with A Twist to raise awareness of cancer; show to air October 12 on ABC
Members: Save time, money with Automatic Dues Renewal and Discounted Multiple Year Dues


LATEST NEWS FROM ASCO More>> 
 

Breast Cancer Symposium Resources Now Available for Purchase 

Oncology professionals can now purchase Virtual Meeting presentations from the 2008 Breast Cancer Symposium through the ASCO.org Virtual Meeting, or as a podcast by purchasing a program subscription.

 

Register and Reserve Housing for 2009 Gastrointestinal Cancers Symposium 

Registration and housing reservations are now available online for the 2009 Gastrointestinal Cancers Symposium: Science and Multidisciplinary Management of GI Malignancies.


CANCER POLICY NEWS More>> 
 

September 3: ASCO Comments on the Medicare Physician Fee Schedule, Congress Returns for Three-Week Legislative Session 


FOR YOUR PATIENT
ASCO Expert Corner: 2008 Breast Cancer Symposium
JCO Cancer Advances: BRCA Mutations Among Asian-American Women May Be More Common than Predicted
Cancer Advances: News for Patients From the 2008 Breast Cancer Symposium
Special Cancer.Net Podcast: 2008 Breast Cancer Symposium Highlights, with Eric Winer, MD
Cancer.Net Guides to Cancer

Due to Hurricane Ike, the submission deadline is
being extended to September 15, 2008 5:00 PM EST

January 15 - 17, 2009
The Moscone West Building
San Francisco, CA


TOP LINKS
Membership Directory 
Abstracts 
Virtual Meeting
Membership Customer Service Area
ASCO-SEP Online

TODAY'S CANCER NEWS More>> 

Voice outcome similar with endoscopic surgery or radiotherapy for glottic cancer

September 15, 2008

NEW YORK (Reuters Health) - As treatments for T1a midcord glottic carcinoma, endoscopic laser surgery and radiotherapy provide similar voice outcomes, according to a report in the Archives of Otolaryngology--Head and Neck Surgery for September.

Her-2/neu DNA vaccine controls refractory Her-2-positive breast cancer in mice

September 15, 2008

NEW YORK (Reuters Health) - Scientists in Michigan have developed a Her-2/neu DNA vaccine that causes rejection of malignant breast tumor cells implanted in mice. According to their report in the September 15 issue of Cancer Research, the vaccine induces a cytotoxic T cell response that is effective even against tumors that are resistant to current Her-2-targeted therapies.


NEWS FROM THE PRESS CENTER More>> 
 

Breast Cancer Symposium Highlights New Studies on Breast Cancer Screening, Treatment and Access to Care 

Washington, DC— New research on breast cancer treatment, detection and disparities in care were released today in advance of the 2008 Breast Cancer Symposium, being held September 5-7, 2008, at the Washington Hilton.

 

2008 Breast Cancer Symposium Awards $14,000 to Oncology Fellows 

Alexandria, VA—Organizers of the 2008 Breast Cancer Symposium today announced the winners of the Symposium Merit Awards. Fourteen physicians-in-training will receive funding to assist with their travel to attend the Symposium, to be held September 5-7 in Washington, DC.


Cancer Types


  Cancer.Net


   Product Spotlight